Scandinavian ChemoTech expands its presence in the Philippines by signing a distribution agreement focusing on the public healthcare system

Today, ChemoTech has signed a distribution agreement with BASEMED KARE Inc. (BASEMED), and thereby increased its efforts to establish a stronger market presence in the Public Healthcare of the Philippines.

BASEMED is a company specialised in distribution and clinical development of Interventional cancer care, an expertise that is very suitable for ChemoTech’s IQwave™ business. The management of BASEMED has more than 20 years of experience in the field of Oncology equipment and applications.

BASEMED’s focus will primarily be to address the public healthcare system and hospitals in the Philippines. The agreement with BASEMED also includes a few of the larger Corporate Hospital groups.

By signing this contract, ChemoTech secures a commercial order from BASEMED KARE Inc.

För mer information vänligen kontakta:

Mohan Frick, VD
Tele: +46 (0)10-218 93 03
Mail: info@chemotech.se

Certified Adviser: Västra Hamnen Corporate Finance AB, Tel: +46 40 200 250, 
E-mail: ca@vhcorp.se

Scandinavian ChemoTech AB (publ)

www.chemotech.seChemoTech is a life science company that possesses great medical expertise and technical knowledge. Our latest Product IQwave™ is an innovation within electroporation, specifically design for Electrochemotherapy for the treatment of different types of tumors. ChemoTech strives to contribute to a more accessible cancer care. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North in Stockholm and Västra Hamnen Corporate Finance AB is the company's Certified Adviser. The company is headquartered at Medicon Village in Lund Sweden, in the midst of the medical technology expansionary Oresund region.